Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors

Among the neuroendocrine neoplasia, the pancreatic somatostatin-producing tumors are very rare. Usually functional, these tumors produce the somatostatinoma syndrome, which encompasses diabetes mellitus, diarrhea/steatorrhoea, and cholelithiasis. Other symptoms may include dyspepsia, weight loss, an...

Full description

Bibliographic Details
Main Authors: Paula Martinez Vianna, Cristiane Rúbia Ferreira, Fernando Peixoto Ferraz de Campos
Format: Article
Language:English
Published: University of São Paulo 2013-03-01
Series:Autopsy and Case Reports
Subjects:
Online Access:http://www.revistas.usp.br/autopsy/article/view/58872
_version_ 1818153600294060032
author Paula Martinez Vianna
Cristiane Rúbia Ferreira
Fernando Peixoto Ferraz de Campos
author_facet Paula Martinez Vianna
Cristiane Rúbia Ferreira
Fernando Peixoto Ferraz de Campos
author_sort Paula Martinez Vianna
collection DOAJ
description Among the neuroendocrine neoplasia, the pancreatic somatostatin-producing tumors are very rare. Usually functional, these tumors produce the somatostatinoma syndrome, which encompasses diabetes mellitus, diarrhea/steatorrhoea, and cholelithiasis. Other symptoms may include dyspepsia, weight loss, anemia, and hypochlorhydria. All theses symptoms are explained by the inhibitory actions of the somatostatin released by tumoral cells originated from pancreatic delta cells or endocrine cells of the digestive tract. The diagnosis is easy to overlook since these symptoms are commonly observed in other more common syndromes. Besides the clinical features, diagnosis is based on serum determination of somatostatin, and imaging exams, such as ultrasound, computer tomography and positron emission tomography. Pathologic examination is characterized by the positivity of immunohistochemical reaction for synaptophysin, chromogranin, and somatostatin. These tumors can be classified according to tumor size, mitotic index, neural or vascular invasion, and distant metastases. The authors describe the case of a 61-year-old female patient who sought medical care because of a 6-month history of watery diarrhea, weight loss, and depression. She was diagnosed with diabetes mellitus 3 years ago. Imaging examination revealed a tumoral mass of 4 cm in its longest axis in the topography of the head of the pancreas and calculous cholecistopathy. The patient’s clinical status was unfavorable for a surgical approach. She died after 20 days of hospitalization. The definitive diagnosis was achieved with the autopsy findings, which disclosed a pancreatic somatostatinoma.
first_indexed 2024-12-11T14:13:11Z
format Article
id doaj.art-2826cdf1a7fb4058906b527387594829
institution Directory Open Access Journal
issn 2236-1960
language English
last_indexed 2024-12-11T14:13:11Z
publishDate 2013-03-01
publisher University of São Paulo
record_format Article
series Autopsy and Case Reports
spelling doaj.art-2826cdf1a7fb4058906b5273875948292022-12-22T01:03:19ZengUniversity of São PauloAutopsy and Case Reports2236-19602013-03-013110.4322/acr.%y.5887257820Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumorsPaula Martinez Vianna0Cristiane Rúbia Ferreira1Fernando Peixoto Ferraz de Campos2Department of Pathology – Faculdade de Medicina – Universidade de São Paulo, São Paulo/SP – BrazilDepartment of Pathology – Faculdade de Medicina – Universidade de São Paulo, São Paulo/SP – BrazilDepartment of Internal Medicine – Hospital Universitário – Universidade de São Paulo, São Paulo/SP - BrazilAmong the neuroendocrine neoplasia, the pancreatic somatostatin-producing tumors are very rare. Usually functional, these tumors produce the somatostatinoma syndrome, which encompasses diabetes mellitus, diarrhea/steatorrhoea, and cholelithiasis. Other symptoms may include dyspepsia, weight loss, anemia, and hypochlorhydria. All theses symptoms are explained by the inhibitory actions of the somatostatin released by tumoral cells originated from pancreatic delta cells or endocrine cells of the digestive tract. The diagnosis is easy to overlook since these symptoms are commonly observed in other more common syndromes. Besides the clinical features, diagnosis is based on serum determination of somatostatin, and imaging exams, such as ultrasound, computer tomography and positron emission tomography. Pathologic examination is characterized by the positivity of immunohistochemical reaction for synaptophysin, chromogranin, and somatostatin. These tumors can be classified according to tumor size, mitotic index, neural or vascular invasion, and distant metastases. The authors describe the case of a 61-year-old female patient who sought medical care because of a 6-month history of watery diarrhea, weight loss, and depression. She was diagnosed with diabetes mellitus 3 years ago. Imaging examination revealed a tumoral mass of 4 cm in its longest axis in the topography of the head of the pancreas and calculous cholecistopathy. The patient’s clinical status was unfavorable for a surgical approach. She died after 20 days of hospitalization. The definitive diagnosis was achieved with the autopsy findings, which disclosed a pancreatic somatostatinoma.http://www.revistas.usp.br/autopsy/article/view/58872SomatostatinomaWeight LossDiarrheaDepressionDiabetes MellitusGallstones
spellingShingle Paula Martinez Vianna
Cristiane Rúbia Ferreira
Fernando Peixoto Ferraz de Campos
Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
Autopsy and Case Reports
Somatostatinoma
Weight Loss
Diarrhea
Depression
Diabetes Mellitus
Gallstones
title Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
title_full Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
title_fullStr Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
title_full_unstemmed Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
title_short Somatostatinoma syndrome: a challenging differential diagnosis among pancreatic tumors
title_sort somatostatinoma syndrome a challenging differential diagnosis among pancreatic tumors
topic Somatostatinoma
Weight Loss
Diarrhea
Depression
Diabetes Mellitus
Gallstones
url http://www.revistas.usp.br/autopsy/article/view/58872
work_keys_str_mv AT paulamartinezvianna somatostatinomasyndromeachallengingdifferentialdiagnosisamongpancreatictumors
AT cristianerubiaferreira somatostatinomasyndromeachallengingdifferentialdiagnosisamongpancreatictumors
AT fernandopeixotoferrazdecampos somatostatinomasyndromeachallengingdifferentialdiagnosisamongpancreatictumors